跳至主要内容
临床试验/EUCTR2018-003042-16-ES
EUCTR2018-003042-16-ES进行中(未招募)1 期

Randomized clinical trial to evaluate the efficacy of fibrin membrane graft with eye drops concentrated in autologous growth factors in primary pterygium surgery comparing it with amniotic membrane graft in terms of recurrence during the first year after surgery

Institut de Recerca H. de la Santa Creu i Sant Pau0 个研究点目标入组 110 人开始时间: 2018年10月9日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • - Uni or bilateral primary pterygium with growth of fibrovascular proliferation.
  • - Patients between 20 and 60 years old
  • - Corneal invasion with risk of visual affectation and / or eye discomfort due to pterygium.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 110
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Prior pterygium surgery (recurrent pterygium)
  • - Pseudopterigio
  • - Use of topical or systemic immunosuppressive or immunomodulatory treatment
  • - Use of chronic topical ocular treatment except artificial tears
  • - Antecedents of palpebral disease or ocular surface

研究者

发起方
Institut de Recerca H. de la Santa Creu i Sant Pau

相似试验